Suchergebnisse - "Yoshifuji, Ayumi"

PubPharm (24)

1

Memory B Cells and Memory T Cells Induced by SARS-CoV-2 Booster Vaccination or Infection Show Different Dynamics and Responsiveness to the Omicron Variant

enthalten in: Journal of immunology (Baltimore, Md. : 1950) | 2022

von Mise-Omata, S. | Ikeda, M. | Takeshita, M. | +17

2

Nafamostat Mesylate Monotherapy in Patients with Moderate COVID-19 : a Single-Center, Retrospective Study

enthalten in: Japanese journal of infectious diseases | 2022

von Soma, T. | Fujii, K. | Yoshifuji, A. | +6

3

T-cell Response and Antibody Production by Booster COVID-19 Vaccination in Japanese Patients with Chronic Kidney Disease Treated with Hemodialysis

enthalten in: Preprints.org | 2022

von Yoshifuji, A. | Toda, M. | Ryuzaki, M. | +22

4

A case of Bacillus subtilis var. natto bacteremia caused by ingestion of natto during COVID-19 treatment in a maintenance hemodialysis patient with multiple myeloma

enthalten in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy | 2022

von Kato, A. | Yoshifuji, A. | Komori, K. | +8

5

Investigation for the efficacy of COVID-19 vaccine in Japanese CKD patients treated with hemodialysis

enthalten in: Renal replacement therapy | 2022

von Yoshifuji, A. | Toda, M. | Ryuzaki, M. | +22

6

Investigation for the efficacy of COVID-19 vaccine in Japanese CKD patients treated with hemodialysis

enthalten in: Renal replacement therapy | 2022

von Yoshifuji, A. | Toda, M. | Ryuzaki, M. | +22

7

Memory B cells and memory T cells induced by SARS-CoV-2 booster vaccination or infection show different dynamics and efficacy to the Omicron variant

enthalten in: bioRxiv.org | 2022

von Mise-Omata, S. | Ikeda, M. | Takeshita, M. | +17

8

Correction to : Factors associated with SARS-CoV-2 antibody titers and prognosis of breakthrough infection in hemodialysis patients

enthalten in: Clinical and experimental nephrology | 2022

von Toda, M. | Yoshifuji, A. | Kikuchi, K. | +7

ErratumFor: Clin Exp Nephrol. 2022 Jun;26(6):571-580. - PMID 35133533

9

Factors associated with SARS-CoV-2 antibody titers and prognosis of breakthrough infection in hemodialysis patients

enthalten in: Clinical and experimental nephrology | 2022

von Toda, M. | Yoshifuji, A. | Kikuchi, K. | +7

ErratumIn: Clin Exp Nephrol. 2022 Mar 9;:. - PMID 35262832

10

Patients with hemodialysis-induced hypoxemia had a poor prognosis of COVID-19

enthalten in: Renal replacement therapy | 2022

von Toda, M. | Yoshifuji, A. | Fujii, K. | +5